• 1 From the *HIV-NAT, the Thai Red Cross AIDS Research Centre, Bangkok, Thailand; †The Kirby Institute, University of New South Wales, Sydney, Australia; ‡Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; §Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand; ¶Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; ‖Division of Infectious Diseases, Department of Pediatrics, Khon Kaen University, Khon Kaen, Thailand; **Research Unit, National Centre for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia; ††Department of Public Health, University of Health Sciences, Phnom Penh, Cambodia; ‡‡Pediatric TB/HIV/AIDS Care Department, National Pediatric Hospital, Phnom Penh, Cambodia; §§YR Gaitonde Centre for AIDS Research and Education, Chennai, India; ¶¶Department of Pediatrics, Penang Hospital, Penang, Malaysia; ‖‖Infectious Disease Department, National Hospital of Pediatrics, Hanoi, Vietnam; ***Department of Pediatrics, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia; †††TREAT Asia/amfAR, The Foundation for AIDS Research, Bangkok, Thailand; and ‡‡‡Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Pediatr. Infect. Dis. J., 2016 Feb;35(2):201-4.
PMID: 26484429 DOI: 10.1097/INF.0000000000000961


We analyzed final height of 273 perinatally HIV-infected Asian adolescents older than 18 years at their last clinic visit. By the World Health Organization child growth reference, 30% were stunted, but by the Thai child growth reference, 19% were stunted. Half of those who were stunted at antiretroviral therapy initiation remained stunted over time. Being male and having a low baseline height-for-age Z score of less than -1.0 were associated with low final height Z score.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.